NCT01540136View on ClinicalTrials.gov

Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma

PHASE3CompletedINTERVENTIONAL
Enrollment

402

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

May 31, 2014

Study Completion Date

July 31, 2016

Conditions
Nasopharyngeal Carcinoma
Interventions
DRUG

Nedaplatin

Nedaplatin 100mg/m2(3 weekly),D1,D22,D43 of RT

DRUG

Cisplatin

Cisplatin 100mg/m2(3 weekly),D1,D22,D43 of RT

Trial Locations (1)

510060

Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou

All Listed Sponsors
collaborator

Guangzhou Medical University

OTHER

collaborator

The First Affiliated Hospital of Guangdong Pharmaceutical University

OTHER

collaborator

Meizhou City Hospital Of Guangdong Provience

UNKNOWN

lead

Sun Yat-sen University

OTHER

NCT01540136 - Concurrent Chemoradiotherapy With Nedaplatin Versus Cisplatin in Nasopharyngeal Carcinoma | Biotech Hunter | Biotech Hunter